# COMPASS Pathways

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/compass-pathways

- Industry: Healthcare Specialists
- Headquarters: Altrincham, UK
- Website: www.compasspathways.com
- Total disclosed funding: $111M
- Latest round: Series B (Apr 27, 2020)
- Investors on record: 10

## About

Founded in 2016 and based in Cheshire, UK, COMPASS Pathways Plc is a mental health care company, The company was co-founded by Executive Chairman and Chief Executive Officer George Goldsmith, Chief Innovation Officer Ekaterina Malievskaia, and President and Chief Business Officer Lars Christian Wilde. In July 2023, COMPASS Pathways Plc raised USD 50 million in venture debt funding from Hercules Capital.

Compass Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company focuses on improving the lives of those who are suffering from mental health and who are not helped by current treatments. The company develops psilocybin therapy, in which its proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support. COMP360 is designated a Breakthrough Therapy by the US Food and Drug Administration (FDA), for treatment-resistant depression (TRD), and conducting a phase IIb clinical trial of psilocybin therapy for TRD, in 22 sites across Europe and North America.

COMPASS Pathways Plc intends to use the July 2023 funding to expand its product development.

## Funding rounds

- Series B, Apr 27, 2020, $80M — Camden Partners, Founders Fund, Perceptive Advisors, Soleus Capital, Able Partners, atai Life Sciences N.V., Skyviews Life Science, McQuade Center, Catalio Capital Management
- Series A, Oct 4, 2019, $31M — Xyence Capital

## Investors

- Xyence Capital (https://capitalatlas.ai/funds/xyence-capital) — Series A
- Camden Partners (https://capitalatlas.ai/funds/camden-partners) — Series B
- Founders Fund (https://capitalatlas.ai/funds/founders-fund) — Series B
- Perceptive Advisors (https://capitalatlas.ai/funds/perceptive-advisors) — Series B
- Soleus Capital (https://capitalatlas.ai/funds/soleus-capital) — Series B
- Able Partners (https://capitalatlas.ai/funds/able-partners) — Series B
- atai Life Sciences N.V. — Series B
- Skyviews Life Science (https://capitalatlas.ai/funds/skyviews-life-science) — Series B
- McQuade Center — Series B
- Catalio Capital Management (https://capitalatlas.ai/funds/catalio-capital-management) — Series B